Skip to main content
OpenTrials

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies
Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV

NCT02671500

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Beijing Ditan Hospital Chaoyang, Beijing Municipality, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • The Third Affiliated Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
View all 38 locations
View Trial Details
Completed

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b

NCT03485846

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations
  • FBIS CSRI of Epidemiology of Federal Service on Customers Moscow, Russia
  • SBEI HPE Moscow State Medical and Dental University n.a. A.I. Evdokimov of Ministry of Health of Russia Moscow, Russia
  • SBHI of Moscow "City Clinical Hospital #24" Moscow, Russia
  • St. Petersburg SBHI Center of Prevention and Fight against AIDS and Infection Diseases Saint Petersburg, Russia
View Trial Details
Completed

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

NCT00894686

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Grieskirchnerstr.17 Oberösterreich, Austria
  • Untergraben 2 Oberösterreich, Austria
  • Dr. Ulrich Behre Baden-Württemberg, Germany
  • Niepubliczny Zakład Opieki Zdrowotnej Ośrodek Zdrowia w Lipsku Zamość, Poland
View Trial Details
Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis

NCT02781558

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de A Coruña A Coruña, Spain
  • Hospital Universitario Fundacion Alcorcon Alcorcón, Spain
  • Hospital General Universitario De Alicante Alicante, Spain
View all 28 locations
View Trial Details

Related conditions